Review Article
Cardiovascular Disease Risk Factors, Type 2 Diabetes Mellitus, and the Framingham Heart Study☆

https://doi.org/10.1016/j.tcm.2010.08.001Get rights and content

Type 2 diabetes is a common disorder and an important risk factor for cardiovascular disease. The Framingham Heart Study is a population-based epidemiologic study that has contributed to our knowledge of cardiovascular disease and its risk factors. This review will focus on the contemporary contributions of the Framingham Heart Study to the field of diabetes epidemiology, including data on diabetes trends, genetics, and future advances in population-based studies.

Section snippets

Description of the Current State of Knowledge

Diabetes mellitus (DM), defined as elevated fasting or postprandial blood sugar or, more recently, the hemoglobin A1c, is increasing in prevalence both in the United States and worldwide. Current estimates of diabetes prevalence by 2030 include 439 million adults worldwide affected (Shaw et al. 2010). Diabetes is associated with increased morbidity and mortality, specifically due to complications, including diabetic retinopathy, neuropathy, nephropathy, and cardiovascular disease (CVD).

Contributions of FHS Past

Diabetes was recognized as a CVD risk factor very early on in the exploration of CVD risk factors in the FHS. Here, diabetes was found to be associated with a two- to four-fold increased risk of myocardial infarction (Kannel and McGee 1979), congestive heart failure (Kannel et al. 1974), peripheral arterial disease (Brand et al. 1989), and stroke (Kannel and McGee 1979) and increased mortality (Kannel and McGee 1979). Moreover, diabetes was consistently found to be a stronger risk factor for

Contributions of FHS Present

The FHS continues to provide insights into the relationships between CVD risk factors, diabetes, and cardiovascular disease, in part owing to 60 years of data, which makes the FHS an ideal setting to study disease trends over time, long-term outcomes, and the natural history of disease. This section will briefly review key contributions of the FHS in this area.

The Future of Diabetes Research in the FHS

The FHS has successfully led to the identification of multiple risk factors for diabetes and for CVD, as well as the interplay between diabetes and CVD. As technology further becomes more common in the FHS and other population-based studies, more unbiased high-throughput screens will be implemented. This is becoming a reality in the Systems Approach to Biomarker Research project in CVD. This project will take a systems biology approach to CVD and its risk factors, including diabetes. This

Questions and Controversies in the Field of Diabetes

One of the major questions and controversies in the field of diabetes as it relates to CVD is the inability to reconcile observational study data with the clinical trial data. Countless studies, including those from Framingham (Meigs et al. 2002b), have demonstrated a linear and graded association between increasing hemoglobin A1c, a longer-term marker of glucose levels, and incident CVD. However, nearly all of the clinical trials among patients with type 2 DM have failed to show a reduction in

Suggestions for Future Research

Future research in the area of diabetes should focus on high-throughput unbiased screens to uncover novel mechanisms and biology of disease. In addition, research should focus on searching for risk factors for CVD that may be more specific to diabetes, such as hypoglycemia or medication-related comorbidities.

In conclusion, the FHS has made important contributions to our knowledge in the area of CVD risk factors, diabetes, and incident CVD. Observational studies can highlight trends and

References (37)

  • DupuisJ. et al.

    New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk

    Nat Genet

    (2010)
  • Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

    Executive summary of the third report of the National Cholesterol Education Program (NCEP) (Adult Treatment Panel III)

    JAMA

    (2001)
  • FoxC.S. et al.

    Trends in cardiovascular complications of diabetes

    JAMA

    (2004)
  • FoxC.S. et al.

    The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study

    Diabetes Care

    (2004)
  • FoxC.S. et al.

    Trends in the incidence of type 2 diabetes mellitus from the 1970s to the 1990s: the Framingham Heart Study

    Circulation

    (2006)
  • FoxC.S. et al.

    Increasing cardiovascular disease burden due to diabetes mellitus: the Framingham Heart Study

    Circulation

    (2007)
  • GenuthS. et al.

    Follow-up report on the diagnosis of diabetes mellitus

    Diabetes Care

    (2003)
  • GersteinH.C. et al.

    Effects of intensive glucose lowering in type 2 diabetes

    N Engl J Med

    (2008)

    • Cited by (127)

    View all citing articles on Scopus
    ☆

    The Framingham Heart Study is supported by the National Heart, Lung, and Blood Institute's Framingham Heart Study (N01-HC-25195).

    View full text
    Copyright © 2010 Published by Elsevier Inc.